Max Robotics — Global Service Robot Directory + US Certification

About

Diana Lin is a pioneering surgical oncologist whose research focuses on advancing precision surgery for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). Her major contributions center on integrating molecular imaging agents into robotic surgical platforms to improve tumor visualization and resection accuracy. In her landmark 2024 study, "Interim Phase II Results Using Panitumumab-IRDye800CW during Transoral Robotic Surgery in Patients with Oropharyngeal Cancer," Lin demonstrated how fluorescence-guided surgery using an EGFR-targeted tracer can overcome the tactile limitations of transoral robotic surgery (TORS). This work, already garnering 15 citations, addresses the critical challenge of achieving clear margins in minimally invasive procedures where surgeons lack direct touch feedback. By enabling real-time tumor detection during TORS, Lin's approach promises to reduce recurrence rates while preserving functional outcomes. Her research sits at the intersection of surgical oncology, biomedical optics, and robotics, offering a transformative solution to the rising incidence of HPV-related OPSCC. Lin's innovative work has positioned her as a leading voice in image-guided robotic surgery, with implications extending to other cancer types where intraoperative visualization remains a clinical hurdle.